Mersana Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of MRSN for the last quarter is 9.24 M USD, and it's 13.61% lower compared to the previous quarter. The net income of Q1 24 is -19.31 M USD.